Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Some here are our worst enemy:

Grow up and stop whining. People buy and sell stock all the time based on different reasons. Since the stock has been under $0.15 for most of this year, a myriad of investors have purchased at this level and just want to secure a profit, knowing that the BOD could make more irresponsible decisions. The stock should move up as more information about MMP licensing in revealed. No matter what you think, the BOD has never provided the vision or management this company needs. The price will go up, but investors will continue to be cautious until the three amigos are replaced.

Share
New Message
Please login to post a reply